UKRAINS'KYI VISNYK PSYKHONEVROLOHII

The Scientific and Practical Journal of Medicine
ISSN 2079-0325(p)
DOI 10.36927/2079-0325
Home » Archive of numbers » 2019 » Volume 27, issue 4 (101) » Modern approaches to the treatment of bipolar aff ective disorder (a review of the recommendations of professional psychiatric association’s)

Modern approaches to the treatment of bipolar aff ective disorder (a review of the recommendations of professional psychiatric association’s)

Authors

Type of Article

  • Scientific Article

In the Section

  • TO HELP A PRACTICING PHYSICIAN

Key words

Index UDK:
  • 616.89+159.96-08

Abstract

The article provides recommendations on the treatment and prevention of bipolar aff ective disorder (BAD) with based on the guidelines of leading professional organizations.

The article describes the treatment algorithms in three stages BAD: the acute phase (stopping), supportive and preventive (anti-relapse) therapy. Highlighted recommendations for the treatment of manic/hypomanic and mixed conditions; bipolar depression and BAD with a fast cycle. The article emphasizes that the choice of the drug is based not only on the level of its proven eff ectiveness and safety, but also on the analysis of clinical features (aff ect polarity, type of course, dominant symptomatology), somatoneurological status, comorbid patho logy and adherence to treatment.

Pages

  • 95-98

Year / Issue

Download PDF

References

  1. Misdiagnosis, duration of untreated illness (DUI) and outcome in bipolar patients with psychotic symptoms: a naturalistic study  / Altamura    C., Buoli  M., Caldiroli  A. [et  al.]  // J Affect Disord. 2015; 182: 70—5. DOI: https://doi.org/10.1016/j.jad.2015.04.024.
  2. Diagnostic and statistical manual of mental disorders  / American Psychiatric Association. 5th ed. Washington, DC  : APA Press, 2013. DOI: https://doi.org/10.1176/appi.books.9780890425596.
  3. Practice guideline for the treatment of patients with bipolar disorder (revision) / American Psychiatric Association // Am J Psychiatry. 2002; 159: 1—50. PMID: 11958165.
  4. Staging in bipolar disorder: from theoretical framework to clinical utility / Berk M., Post R., Ratheesh A. [et al.] // World Psychiatry. 2017; 16: 236—44. DOI: https://doi.org/10.1002/wps.20441.
  5. Concept paper on the need for revision of  the note for guidance on  clinical investigation of  medicinal products for the treatment and prevention of  bipolar disorder  / European Medicines Agency scientific committee. 2016. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2016/07/WC500211317.pdf.
  6. The prevalence and burden of bipolar disorder: findings from the Global Burden of Disease Study 2013  / Ferrari    J., Stockings  E., Khoo  J.  P. [et  al.]  // Bipolar Disord. 2016; 18: 440—50. DOI: https://doi.org/10.1111/bdi.12423.
  7. Atypical antipsychotics in the treatment of acute bipolar depression with mixed features: a systematic review and exploratory meta-analysis of  placebo-controlled clinical trials  / Fornaro  , Stubbs B., De  B.  D. [et  al.]  // Int  J  Mol  Sci. 2016. 17(2): 241. DOI: https://doi.org/10.3390/ijms17020241.
  8. The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 3: The Clinical Guidelines / Fountoulakis K. N., Grunze H., Vieta E. [et al.] // Int J of Neuropsychopharmacology. 2017; 20 (2): 180—195. DOI: https://doi.org/10.1093/ijnp/pyw109.
  9. Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology / Goodwin    M., Haddad P. M., Ferrier I. N. [et al.] // J Psychopharmacol (Oxford). 2016. 30: 495—553. DOI: https://doi.org/10.1177/0269881116636545.
  10. Grande I., Berk M., Birmaher B., Vieta E. Bipolar disorder // Lancet. 2016. 387(10027): 1561—1572. DOI: https://doi.org/10.1016/S0140-6736(15)00241-X.
  11. Grunze H., Azorin J. Clinical decision making in the  treatment of  mixed states  // World J  Biol Psychiatry. 2014. 15(5): 355—368. DOI: https://doi.org/10.3109/15622975.2014.908238.
  12. The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Acute and long-term treatment of mixed states in  bipolar disorder  / Grunze H., Vieta E., Goodwin    M. [et  al.]  // The  World Journal of  Biological Psychiatry. 2018. DOI: https://doi.org/10.1080/15622975.2017.1384850.
  13. Psychosocial disability and work role function compared across the long-term course of bipolar I, bipolar II and unipolar major depressive disorders / Judd L. L., Schettler P. J., Solomon D. A. [et al.] // J Affect Disord. 2008; 108(1—2): 49—58. DOI: https://doi.org/10.1016/j.jad.2007.06.014.
  14. Kessing L. V., Andersen P. K. Evidence for clinical progression of unipolar and bipolar disorders // Acta Psychiatr Scand. 2017; 135(1): 51—64. DOI: https://doi.org/10.1111/acps.12667.
  15. Long-term naturalistic follow-up of patients with bipolar depression and mixed state treated with electroconvulsive therapy / Medda P., Mauri M., Fratta S. [et ]  // J  ECT. 29(3): 179—188. DOI: https://doi.org/10.1097/YCT.0b013e3182887b7a.
  16. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative / Merikangas K. R., Jin R., He J-P. [et al.] // Arch Gen Psychiatry. 2011; 68: 241—51. DOI: https://doi.org/10.1001/archgenpsychiatry.2011.12.
  17. Comparative efficacy and tolerability of pharmacological treatments in the maintenance treatment of bipolar disorder: a systematic review and network meta-analysis / Miura  , Noma  H., Furukawa T.  A. [et  al.]  // Lancet Psychiatry. 2014. 1: 351—359. DOI: https://doi.org/10.1016/S2215-0366(14)70314-1.
  18. The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in  bipolar disorders  / Pacchiarotti  , Bond D.  J., Baldessarini R.  J. [et  al.]  // Am  J  Psychiatry. 2013. 170: 1249—1262. DOI: https://doi.org/10.1176/appi.ajp.2013.13020185.
  19. Radua J., Grunze H., Amann B. L. Meta-analysis of the risk of subsequent mood episodes in bipolar disorder // Psychother Psychosom. 2017. 86: 90—98. DOI: https://doi.org/10.1159/000449417.
  20. Onset polarity and illness course in bipolar I and II disorders: The predictive role of broadly defined mixed states  / Tundo A., Musetti L., Benedetti A. [et al.] // Compr Psychiatry. 2015. 63: 15—21. DOI: https://doi.org/10.1016/j.comppsych.2015.07.018.
  21. Van Rheenen T. E, Rossell S. L. Objective and subjective psychosocial functioning in bipolar disorder: an investigation of the relative importance of neurocognition, social cognition and emotion regulation // J Affect Disord. 2014; 162: 134—41. DOI: https://doi.org/10.1016/j.jad.2014.03.043.
  22. Continuation of quetiapine versus switching to placebo or lithium for maintenance treatment of bipolar I disorder (Trial 144: a randomized controlled study) / Weisler R. H., Nolen W. A., Neijber A. [et al.] // J Clin Psychiatry. 2011. 72: 1452—1464. DOI: https://doi.org/10.4088/JCP.11m06878.
  23. Preventing bipolar relapse: In which way do patients with mixed episodes differ? / Wilhelm S., Schacht A., Minarzyk A. [et  ]  // Eur  Psychiatry. 2007. 22: S  262. DOI: https://doi.org/10.1016/j.eurpsy.2007.01.882.
  24. A diagnosis of bipolar spectrum disorder predicts diagnostic conversion from unipolar depression to bipolar disorder: a 5-year retrospective study / Woo Y. S., Shim I. H., Wang H. R. // J Affect Disord. 2015. 174: 83—88. DOI: https://doi.org/10.1016/j.jad.2014.11.034.
  25. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder / Yatham L. N, Kennedy S. , Parikh S.  V. [et  al.]  // Bipolar Disord. 2018; 20: 97—170. DOI: https://doi.org/10.1111/bdi.12609.

Journal’s Indexing:

UKRAINS'KYI VISNYK PSYKHONEVROLOHII

The Scientific and Practical Journal of Medicine

ДУ «ІНПН імені
П.В. ВОЛОШИНА
НАМН УКРАЇНИ»